This article is more than 5 years old. Information may no longer be current.
MD Anderson names provost, executive VP
Ethan Dmitrovsky, MD, will serve as the next provost and executive vice president at The University of Texas MD Anderson Cancer Center.
Dmitrovsky, professor and chair of the department of pharmacology and toxicology at the Geisel School of Medicine at Dartmouth, will direct MD Anderson’s research and educational programs. He will be responsible for the execution of its Moon Shots Program, designed to accelerate the pace at which scientific discoveries are converted into clinical advances to reduce cancer deaths.
“Ethan Dmitrovsky is an outstanding leader as well as a highly accomplished scientist and lung cancer clinician who knows what it takes to successfully connect those two roles as a physician-scientist to improve our understanding and treatment of cancer,” Ronald DePinho, MD, president of MD Anderson, said in a press release.
Ethan Dmitrovsky
Dmitrovsky joined the faculty at Memorial Sloan-Kettering Cancer Center in 1987 and moved to Dartmouth in 1998. He will begin his new role at MD Anderson on July 15.
Dmitrovsky’s primary research area is lung cancer. He and his colleagues discovered a protein-destroying pathway responsible for retinoids’ effects on cancer, and they developed a mouse model that closely reflects human lung cancer development and targets proteins that prevent destruction of the PML-RARalpha fusion protein. He and his team also helped establish the use of all-trans retinoic acid for promyelocytic leukemia.